Medications
Basel, October 9, 2018 – Results from a post hoc analysis of the Phase II SUSTAIN study of crizanlizumab, a humanized anti-P-selectin monoclonal antibody being investigated for the
Read More
Medications
(HealthDay)—With millions of pain-plagued Americans looking for an alternative to opioids, the solution for some might be no medicine at all. New research suggests that a good many
Read More